Treatment-free survival after first-line therapies for metastatic renal cell carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) analysis.

被引：0
|
作者：
Gupta, Mehul
Wells, Connor
Regan, Meredith M.
Xie, Wanling
Navani, Vishal
Saliby, Renee Maria
Basappa, Naveen S.
Donskov, Frede
Yuasa, Takeshi
Takemura, Kosuke null
Kollmannsberger, Christian K.
Crumbaker, Megan
Lalani, Aly-Khan A.
Powles, Thomas
Pal, Sumanta Kumar
Mckay, Rana R.
Lee, Jae-Lyun
Kanesvaran, Ravindran
Choueiri, Toni K.
Heng, Daniel Yick Chin
机构：
[1] Univ Calgary, Arnie Charbonneau Canc Res Inst, Calgary, AB, Canada
[2] BC Canc Agcy, Vancouver, BC, Canada
[3] Dana Farber Canc Inst, Boston, MA USA
[4] Dana Farber Canc Inst, Dept Data Sci, Boston, MA USA
[5] Univ Calgary, Tom Baker Canc Ctr, Calgary, AB, Canada
[6] Univ Alberta, Cross Canc Inst, Edmonton, AB, Canada
[7] Univ Hosp, Aarhus, Denmark
[8] Japanese Fdn Canc Res, Canc Inst Hosp, Tokyo, Japan
[9] British Columbia Canc Agcy, Vancouver, BC, Canada
[10] St Vincents Hosp, Sydney, NSW, Australia
[11] McMaster Univ, Juravinski Canc Ctr, Dept Oncol, Hamilton, ON, Canada
[12] Barts Canc Inst, London, England
[13] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA
[14] Univ Calif San Diego, San Diego, CA USA
[15] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea
[16] Natl Canc Ctr, Singapore, Singapore
[17] Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 4_SUPPL期
关键词：
281-5277-5597; 283-2494-9200; 261-566-9263; 130-540-543-4790; 130-540-543-12277; 261-492-3532-2370-2813-7645; 261-566-11347; 7; 6; 5; 3; 2; 137; 4; 2434; 171; 319; 1;
D O I：
10.1200/JCO.2024.42.4_suppl.390
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：390 / 390
页数：1
相关论文
共 50 条
  • [1] Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis
    Gupta, Mehul
    Wells, Connor
    Regan, Meredith M.
    Xie, Wanling
    Navani, Vishal
    Saliby, Renee Maria
    Basa, Naveen S.
    Donskov, Frede
    Yuasa, Takeshi
    Takemura, Kosuke
    Kollmannsberger, Christian K.
    Crumbaker, Megan
    Lalani, Aly-Khan A.
    Powles, Thomas
    Ebrahimi, Hedyeh
    Mckay, Rana R.
    Lee, Jae-Lyun
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY ONCOLOGY, 2025, 8 (01): : 171 - 178
  • [2] First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Roussel, Eduard
    Kinget, Lisa
    Beuselinck, Benoit
    Albersen, Maarten
    Wells, Connor
    Ernst, Matthew Scott
    Donskov, Frede
    Schmidt, Andrew Lachlan
    Szabados, Bernadett
    Pal, Sumanta K.
    Meza, Luis A.
    Agarwal, Neeraj
    Weickhardt, Andrew James
    Davis, Ian D.
    Alva, Ajjai Shivaram
    Wood, Lori
    Porta, Camillo
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Navani, Vishal
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [3] Characterization of patients with metastatic renal cell carcinoma achieving complete response to first-line therapies: Results from the international metastatic renal cell carcinoma database consortium (IMDC)
    Takemura, K.
    Navani, V.
    Ernst, M. S.
    Wells, J. C.
    Choueiri, T. K.
    Meza, L.
    Pal, S. K.
    Lee, J-L.
    Li, H.
    Agarwal, N.
    Alva, A. S.
    Hansen, A. R.
    Basappa, N. S.
    Szabados, B. E.
    Powles, T. B.
    Tran, B.
    Hocking, C. M.
    Beuselinck, B.
    Yuasa, T.
    Heng, D. Y. C.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1209 - S1210
  • [4] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Wells, J. Connor
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Knox, Jennifer J.
    Beuselinck, Benoit
    Vaishampayan, Ulka N.
    Brugarolas, James
    Broom, Reuben James
    Bamias, Aristotelis
    Yuasa, Takeshi
    Srinivas, Sandhya
    Ernst, D. Scott
    Pezaro, Carmel Jo
    Wood, Lori
    Kollmannsberger, Christian K.
    Rini, Brian I.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma (mRCC): Results from the international metastatic renal cell carcinoma database consortium (IMDC).
    Morales, Jose Manuel Ruiz
    Swierkowski, Marcin
    Wells, Connor
    Fraccon, Anna Paola
    La Russa, Francesca
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Beuselinck, Benoit
    Wood, Lori
    Yuasa, Takeshi
    Pezaro, Carmel Jo
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma
    Ernst, Matthew S.
    Navani, Vishal
    Wells, J. Connor
    Donskov, Frede
    Basappa, Naveen
    Labaki, Chris
    Pal, Sumanta K.
    Meza, Luis
    Wood, Lori A.
    Ernst, D. Scott
    Szabados, Bernadett
    McKay, Rana R.
    Parnis, Francis
    Suarez, Cristina
    Yuasa, Takeshi
    Lalani, Aly-Khan
    Alva, Ajjai
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY, 2023, 84 (01) : 109 - 116
  • [7] Predictors of objective response to first-line immuno-oncology combination therapies in metastatic renal cell carcinoma: Results from the international metastatic renal cell database consortium (IMDC).
    Navani, Vishal
    Ernst, Matthew Scott
    Wells, Connor
    Yuasa, Takeshi
    Takemura, Kosuke
    Donskov, Frede
    Basappa, Naveen S.
    Schmidt, Andrew Lachlan
    Pal, Sumanta K.
    Meza, Luis A.
    Wood, Lori
    Ernst, D. Scott
    Szabados, Bernadett
    McKay, Rana R.
    Weickhardt, Andrew James
    Suarez, Cristina
    Kapoor, Anil
    Lee, Jae-Lyun
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [8] First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Ruiz-Morales, Jose Manuel
    Swierkowski, Marcin
    Wells, J. Connor
    Fraccon, Anna Paola
    Pasini, Felice
    Donskov, Frede
    Bjarnason, Georg A.
    Lee, Jae-Lyun
    Sim, Hao-Wen
    Sliwczynsk, Andrzej
    Ptak-Chmielewska, Aneta
    Teter, Zbigniew
    Beuselinck, Benoit
    Wood, Lori A.
    Yuasa, Takeshi
    Pezaro, Carmel
    Rini, Brian I.
    Szczylik, Cezary
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN JOURNAL OF CANCER, 2016, 65 : 102 - 108
  • [9] Characterization of Patients With Metastatic Renal Cell Carcinoma Experiencing Complete Response to First-line Therapies: Results From the International Metastatic Renal Cell Carcinoma Database Consortium
    Takemura, Kosuke
    Navani, Vishal
    Ernst, Matthew S. S.
    Wells, J. Connor
    Meza, Luis
    Pal, Sumanta K. K.
    Lee, Jae-Lyun
    Li, Haoran
    Agarwal, Neeraj
    Alva, Ajjai S. S.
    Hansen, Aaron R. R.
    Basappa, Naveen S. S.
    Szabados, Bernadett
    Powles, Thomas
    Tran, Ben
    Hocking, Christopher M. M.
    Beuselinck, Benoit
    Yuasa, Takeshi
    Choueiri, Toni K. K.
    Heng, Daniel Y. C.
    JOURNAL OF UROLOGY, 2023, 209 (04): : 701 - 709
  • [10] First-line mTOR inhibition in metastatic renal cell carcinoma (mRCC): An updated analysis from the International mRCC Database Consortium (IMDC).
    Harshman, Lauren Christine
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas Kiran
    Vaishampayan, Ulka N.
    Rini, Brian I.
    Knox, Jennifer J.
    North, Scott A.
    MacKenzie, Mary J.
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta Kumar
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345